Skip to Main Content

Paper Details

Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib.
Clin Genitourin Cancer
2
2017
EGFR, Erlotinib, Metastatic Mucinous Urethral Adenocarcinoma
Author NameAffiliation
Alan H BryceMayo Clinic, AZ Mayo Clinic Cancer Center, AZ Center for Individualized Medicine
Winnie S LiangTranslational Genomics Research Institute
Rafael FonsecaMayo Clinic, AZ Mayo Clinic Cancer Center, AZ Center for Individualized Medicine
Thai H HoMayo Clinic, AZ Mayo Clinic Cancer Center, AZ Center for Individualized Medicine
Robert W WilliamsCenter for Individualized Medicine, Mayo Clinic, MN Mayo Clinic Cancer Center
Robert W WilliamsCenter for Individualized Medicine, Mayo Clinic, MN Mayo Clinic Cancer Center
Angela BakerTranslational Genomics Research Institute
Sara NasserTranslational Genomics Research Institute
Daniel D Von HoffTranslational Genomics Research Institute
David W CraigTranslational Genomics Research Institute
Alexander Keith StewartMayo Clinic, AZ Mayo Clinic Cancer Center, AZ Center for Individualized Medicine
John D CarptenTranslational Genomics Research Institute
  • 1 - 12

Datasets

Release 1.2